Brief: Scilex Holding Company Announces Financing Of Up To $25 Million To Enhance Commercialization Of Three FDA Approved Non-Opioid Pain Management Products
21/03/2023 13:07
March 21 (Reuters) - Scilex Holding Co SCLX.O :
* SCILEX HOLDING COMPANY ANNOUNCES FINANCING OF UP TO $25
MILLION
TO ENHANCE COMMERCIALIZATION OF THREE FDA APPROVED NON-OPIOID
PAIN MANAGEMENT PRODUCTS
* SCILEX HOLDING-ENTERED INTO SECURITIES PURCHASE AGREEMENT
WITH
YA II PN, LTD FOR ISSUANCE, SALE OF UNSECURED CONVERTIBLE
DEBENTURES OF UP TO $25 MILLION
Source text for Eikon: ID:nGNX1dkKr1
Further company coverage: SCLX.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Sorrento Therapeutics
See all newsBrief: Scilex Holding Says US Bankruptcy Court Extended Lockup Period On Shares Of Scilex Stock
Company's PO box allows it to file for bankruptcy in Texas, judge rules
Latham, Jackson Walker avoid sanctions over bankruptcy forum shopping dispute (updated)
Latham, Jackson Walker avoid sanctions over bankruptcy forum shopping dispute
Brief: Sorrento Therapeutics Reduced U.S. Headcount From 215 To 128 on Sept. 20